TMAO can promote HCC cell proliferation, migration, and invasion via the periostin/integrin-linked kinase/protein kinase B/mechanistic target of rapamycin signaling axis (Wu et al., 2022). The gene discussed is AKT1; the disease is hepatocellular carcinoma.